Business Daily.
.
A+ R A-

Research and Markets: Combination Inhalers for Upper Airway Diseases - Forecasts for Dual Drug Oral Inhaler Products to 2022

E-mail Print PDF
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fvs4c4/combination) has announced the addition of the "Combination Inhalers for Upper Airway Diseases" report to their offering. Combination inhalers for upper airway diseases - oral inhalers containing two drugs that complement the therapeutic actions of one another - have seen a significant increase in development activity and product proliferation in the past five years. Growth is being driven by improv

imageimage
Grow Your Business with Times Media
Business Daily Media